Dépôt DSpace/Manakin

Allogeneic Bone Impregnated with Biodegradable Depot Delivery Systems for the Local Treatment of Joint Replacement Infections: An In Vitro Study

Afficher la notice abrégée

dc.rights.license CC BY eng
dc.contributor.author Prokes, Libor cze
dc.contributor.author Snejdrova, Eva cze
dc.contributor.author Soukup, Tomas cze
dc.contributor.author Malakova, Jana cze
dc.contributor.author Frolov, Vladislav cze
dc.contributor.author Loskot, Jan cze
dc.contributor.author Andrýs, Rudolf cze
dc.contributor.author Kucera, Tomas cze
dc.date.accessioned 2025-12-05T11:27:12Z
dc.date.available 2025-12-05T11:27:12Z
dc.date.issued 2022 eng
dc.identifier.issn 1420-3049 eng
dc.identifier.uri http://hdl.handle.net/20.500.12603/1585
dc.description.abstract Although progress is evident in the effective treatment of joint replacement-related infections, it still remains a serious issue in orthopedics. As an example, the local application of antibiotics-impregnated bone grafts supplies the high drug levels without systemic side effects. However, antibiotics in the powder or solution form could be a risk for local toxicity and do not allow sustained drug release. The present study evaluated the use of an antibiotic gel, a water-in-oil emulsion, and a PLGA microparticulate solid dispersion as depot delivery systems impregnating bone grafts for the treatment of joint replacement-related infections. The results of rheological and bioadhesive tests revealed the suitability of these formulations for the impregnation of bone grafts. Moreover, no negative effect on proliferation and viability of bone marrow mesenchymal stem cells was detected. An ex vivo dissolution test of vancomycin hydrochloride and gentamicin sulphate from the impregnated bone grafts showed a reduced burst and prolonged drug release. The PLGA-based formulation proved to be particularly promising, as one-day burst release drugs was only 15% followed with sustained antibiotics release with zero-order kinetics. The results of this study will be the basis for the development of a new product in the Tissue Section of the University Hospital for the treatment of bone defects and infections of joint replacements. eng
dc.format p. "Article Number: 6487" eng
dc.language.iso eng eng
dc.publisher MDPI eng
dc.relation.ispartof MOLECULES, volume 27, issue: 19 eng
dc.subject drug delivery eng
dc.subject biocompatibility eng
dc.subject cell culture eng
dc.subject bone graft eng
dc.subject local antibiotic eng
dc.subject PLGA eng
dc.subject water-in-oil emulsion eng
dc.subject hydrogel eng
dc.title Allogeneic Bone Impregnated with Biodegradable Depot Delivery Systems for the Local Treatment of Joint Replacement Infections: An In Vitro Study eng
dc.type article eng
dc.identifier.obd 43879140 eng
dc.identifier.wos 000867927500001 eng
dc.identifier.doi 10.3390/molecules27196487 eng
dc.publicationstatus postprint eng
dc.peerreviewed yes eng
dc.source.url https://www.mdpi.com/1420-3049/27/19/6487 cze
dc.relation.publisherversion https://www.mdpi.com/1420-3049/27/19/6487 eng
dc.rights.access Open Access eng


Fichier(s) constituant ce document

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Chercher dans le dépôt


Parcourir

Mon compte